Skip to main content

Agencourt, Ambion Pen Reagent Distribution Deal

NEW YORK, Sept. 16 (GenomeWeb News) - Agencourt Bioscience said today that it has signed a distribution agreement with Ambion for its SPRI (Solid-Phase Reversible Immobilization) nucleic acid purification reagent.

Under the terms of the agreement, Ambion will distribute the reagent, called AMPure, as part of its MessageAmp RNA amplification kit.

Further details about the agreement were not provided.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.